Antares Pharma buy melinda
Start price
08.10.17
/
50%
€3.97
Target price
19.12.17
€4.20
Performance (%)
-48.24%
End price
19.12.17
€2.06
Summary
This prediction ended on 19.12.17 with a price of €2.06. The BUY prediction by melinda for Antares Pharma performed very badly with a performance of -48.24%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Antares Pharma | - | - | - | - |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % | 65,85 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % | 93,30 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % | 89,08 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % | 71,94 % |
Comments by melinda for this prediction
In the thread Antares Pharma diskutieren
Kaution ANDS angekündigt 17. April 2017. PDUFA Datum 17. Oktober 2017 eine vorrangige Prüfung von 6 Monaten angenommen.
(Vom Mitglied beendet)